» Articles » PMID: 21705979

GH Deficiency in Adult B-thalassemia Major Patients and Its Relationship with IGF-1 Production

Overview
Date 2011 Jun 28
PMID 21705979
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Endocrine complications in Β-thalassemia represent a prominent cause of morbidity. Above all, dysfunction of GH-IGF-1 axis is of a major concern because of its pathogenic role on cardiac and bone disease, frequently described in this clinical setting. The aim of this paper is to analyze GH-IGF-1 axis in a cohort of 25 adult patients affected by Β-thalassemia. We found that GH deficiency was present in only 8% of our patients if diagnosis was based on GH peak below 9μg/L to two GH provocative tests instead of only one, and was mainly related to iron overload. On the contrary, IGF-1 production was impaired in a higher percentage of patients (72%), without significant correlation with iron burden. Of note, patients with hepatitis C virus infection showed lower IGF-1 concentrations than uninfected subjects despite a normal GH reserve, suggesting that partial GH insensitivity at the post-receptor level may play a key role in IGF-1 deficiency described in thalassemic patients.

Citing Articles

GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study.

Gagliardi I, Mungari R, Gamberini M, Fortini M, Dassie F, Putti M J Endocrinol Invest. 2022; 45(7):1439-1445.

PMID: 35305249 PMC: 9184367. DOI: 10.1007/s40618-022-01780-z.


Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis.

Yassin M, Abdel Rahman M, Hamad A, Poil A, Abdelrazek M, Hussein R Medicine (Baltimore). 2020; 99(51):e23637.

PMID: 33371098 PMC: 7748343. DOI: 10.1097/MD.0000000000023637.


An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations.

De Sanctis V, Soliman A, Canatan D, Tzoulis P, Daar S, Di Maio S Acta Biomed. 2019; 89(4):481-489.

PMID: 30657116 PMC: 6502100. DOI: 10.23750/abm.v89i4.7774.


Growth and Endocrine Function in Tunisian Thalassemia Major Patients.

Guirat Dhouib N, Ben Khaled M, Ouederni M, Besbes H, Kouki R, Mellouli F Mediterr J Hematol Infect Dis. 2018; 10(1):e2018031.

PMID: 29755708 PMC: 5937976. DOI: 10.4084/MJHID.2018.031.


Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.

Scacchi M, Danesi L, Cattaneo A, Sciortino G, Radin R, Ambrogio A Endocrine. 2016; 53(2):551-7.

PMID: 26825070 DOI: 10.1007/s12020-016-0865-1.